Pharmadrug acquires Canurta

Pharmadrug agreed to acquire Canurta. Reported deal value: Undisclosed. Status: Pending. Sector: Biotechnology. Target headquarters context: Canada.

This page summarizes publicly available information about the transaction as of 2026-01-05. Figures and status may change as filings and press coverage update.

Monday at 9:00am AST · January 5, 20 26 · 10 min read Toronto , Ontario – – PharmaDrug Inc. ( PharmaDrug ” or the Company ), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has closed the previously announced acquisition (the Transaction ) of limited partnership units of Canurta Limited Partnership ( Canurta ), the parent entity of Canurta Inc. , a biotechnology company pioneering novel botanical therapeutics for inflammatory and neurodegenerative diseases